Your browser doesn't support javascript.
loading
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Yu, Alice L; Gilman, Andrew L; Ozkaynak, M Fevzi; Naranjo, Arlene; Diccianni, Mitchell B; Gan, Jacek; Hank, Jacquelyn A; Batova, Ayse; London, Wendy B; Tenney, Sheena C; Smith, Malcolm; Shulkin, Barry L; Parisi, Marguerite; Matthay, Katherine K; Cohn, Susan L; Maris, John M; Bagatell, Rochelle; Park, Julie R; Sondel, Paul M.
Afiliación
  • Yu AL; University of California in San Diego, San Diego, California. a1yu@ucsd.edu pmsondel@humonc.wisc.edu.
  • Gilman AL; Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
  • Ozkaynak MF; PRA Health Services, Raleigh, North Carolina.
  • Naranjo A; New York Medical College, Valhalla, New York.
  • Diccianni MB; Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida.
  • Gan J; University of California in San Diego, San Diego, California.
  • Hank JA; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Batova A; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • London WB; University of California in San Diego, San Diego, California.
  • Tenney SC; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts.
  • Smith M; Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida.
  • Shulkin BL; National Cancer Institute, Bethesda, Maryland.
  • Parisi M; Saint Jude Children's Research Hospital, Memphis, Tennessee.
  • Matthay KK; Seattle Children's Hospital and University of Washington School of Medicine, Seattle, Washington.
  • Cohn SL; University of California School of Medicine and UCSF Children's Hospital, San Francisco, California.
  • Maris JM; University of Chicago, Chicago, Illinois.
  • Bagatell R; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • Park JR; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
  • Sondel PM; Seattle Children's Hospital and University of Washington School of Medicine, Seattle, Washington.
Clin Cancer Res ; 27(8): 2179-2189, 2021 04 15.
Article en En | MEDLINE | ID: mdl-33504555

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 7_non_communicable_diseases / 7_nutrition Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-2 / Anticuerpos Monoclonales / Neuroblastoma Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 7_non_communicable_diseases / 7_nutrition Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Interleucina-2 / Anticuerpos Monoclonales / Neuroblastoma Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
...